Every SEC Form 3/4/5 on record for this filer (CIK 1640592) — 1 issuer, 3 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| LOGC | LogicBio Therapeutics, Inc. | President, CEO · Director · lapsed | 2018-10-18 → 2022-11-17 | 9 | −$43,216 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| LOGC | 2021-04-16 | Sell | 7,542 | $5.73 | $43,216 | 253,811 |